355013-79-5

Usage

Uses

Used in Pharmaceutical Industry:
4-ChloroMethyl-2-Methoxy-pyridine is used as an intermediate in the synthesis of various pharmaceuticals for its role in the production of pyridine derivatives, which are essential components in many drug molecules.
Used in Agrochemical Industry:
4-ChloroMethyl-2-Methoxy-pyridine is used as an intermediate in the synthesis of agrochemicals, contributing to the development of effective pesticides and other agricultural products.
Used in Drug Development:
4-ChloroMethyl-2-Methoxy-pyridine is used as a building block in the development of new drug candidates due to its potential anti-inflammatory and analgesic properties, offering a promising avenue for the creation of novel therapeutic agents.
Used in Chemical Research:
4-ChloroMethyl-2-Methoxy-pyridine is utilized in chemical research for studying its properties and potential applications, furthering the understanding of its role in various chemical reactions and processes.

Upstream product

• 123148-66-3 2-methoxy-4-(hydroxymethyl)-pyridine 
• 105596-63-2 2-methoxy-isonicotinic acid 
• 26156-51-4 methyl 2-methoxyisonicotinate 
• 58481-11-1 methyl 2-chloroisonicotinate 

Downstream Products

• 764708-27-2 2-(2-methoxypyridin-4-yl)ethylamine 
• 1395552-82-5 2-(4-bromo-3-fluorophenyl)-N-[2-(2-methoxypyridin-4-yl)ethyl]-6-methylpyrimidin-4-amine 
• 764708-39-6 C₁₈H₁₆BrFN₄O 
• 764708-28-3 2-(4-bromo-2,5-difluorophenyl)-N-[2-(2-methoxypyridin-4-yl)ethyl]-6-methylpyrimidin-4-amine 
• 1395552-89-2 2-(4-chloro-2,5-difluorophenyl)-N-[2-(2-methoxypyridin-4-yl)ethyl]-6-methylpyrimidin-4-amine 
• 1395552-94-9 2-(4-chloro-2,5-difluorophenyl)-6-ethyl-N-[2-(2-methoxypyridin-4-yl)ethyl]pyrimidin-4-amine 
• 764708-29-4 4-(2-{[2-(4-Bromo-2,5-difluorophenyl)-6-methylpyrimidin-4-yl]amino}ethyl)pyridin-2(1H)-one 
• 794485-71-5 4-(2-{[2-(4-chloro-2,5-difluorophenyl)-6-methylpyrimidin-4-yl]amino}ethyl)pyridin-2(1H)-one 
• 795266-61-4 4-(2-{[2-(4-chloro-2,5-difluorophenyl)-6-ethylpyrimidin-4-yl]amino}ethyl)pyridin-2(1H)-one 

Relevant academic research and scientific papers

PYRAZOLO[3,4-b]PYRIDINES AND IMIDAZO[1,5-b]PYRIDAZINES AS PDE1 INHIBITORS

The present invention provides compounds of formula (I) that are PDE1 enzyme inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders. The present invention also provides pharmaceutical compositions comprising compounds of the invention and methods of treating disorders using the compounds of the invention.

Discovery and biological evaluation of novel 4-amino-2-phenylpyrimidine derivatives as potent and orally active GPR119 agonists

Novel 4-amino-2-phenylpyrimidine derivatives were synthesized and evaluated as GPR119 agonists. Optimization of the substituents on the phenyl ring at the 2-position and the amino group at the 4-position led to the identification of 3,4-dihalogenated and

QUINOLINE AMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

The present invention is directed to quinoline amide compounds of formula (I) which are M1 receptor positive allosteric modulators and that are useful in the treatment of diseases in which the M1 receptor is involved, such as Alzheimer's disease, schizophrenia, pain or sleep disorders. The invention is also directed to pharmaceutical compositions comprising the compounds, and to the use of the compounds and compositions in the treatment of diseases mediated by the M1 receptor.

Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase

The invention relates to pyridine derivatives of formula (I), wherein the substituents and symbols are defined as indicated in the description, processes for the preparation thereof, their usage in the preparation of a pharmaceutical composition for the treatment of a disease which responds to an inhibition of angiogenesis, and pharmaceutical compositions containing such compounds.